Results 131 to 140 of about 112,704 (293)
Botulinum toxin use in patients with neurological disorders: A U.S.‐based claims database analysis
Abstract Background and Objective Real‐world evidence describing long‐term persistency with botulinum toxin (BoNT) therapy is limited. We assessed treatment patterns and persistency with BoNT in clinical practice over 2 years. Design Retrospective, longitudinal, claims database analysis. Setting Medical claims data from the Merative MarketScan database
David M. Simpson +4 more
wiley +1 more source
Abstract Background Hip adductor spasticity is a common affliction among patients with disorders of the central nervous system. Cryoneurolysis is a novel intervention for spasticity involving the application of extreme cold to a nerve. This induces axonal breakdown, relieving spasticity.
Fraser MacRae +2 more
wiley +1 more source
Abstract Introduction/Objective Diagnostic nerve blocks (DNBs) involve the injection of anesthetic around peripheral nerves to temporarily reduce motor tone. Although they are used clinically to inform spasticity treatment with neurotomy and chemodenervation, there is little research exploring the predictive nature of DNBs.
Katherine Archibold +3 more
wiley +1 more source
Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population. [PDF]
Kazerooni R, Watanabe JH.
europepmc +1 more source
Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections [PDF]
Distributed via the CDC Health Alert NetworkApril 23 2024, 11:00 AM ETCDCHAN-00507The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to alert clinicians about risks of counterfeit or mishandled
core
Abstract Introduction Posterior shoulder subluxation and glenohumeral dysplasia are known secondary complications of birth brachial plexus palsies (BBPP) that contribute to functional limitations. The prevalence of shoulder subluxation in infants with BBPP and the timeline of when subluxation occurs in the first year of life remain unclear, with prior ...
Gabrielle Goodlin +5 more
wiley +1 more source
Nanobodies which are single-domain antibodies derived from the Variable Heavy domain of Heavy-chain-only antibodies (VHHs) found in camels and sharks, represent a novel approach for enhancing the detection and neutralization of food toxins.
Luong Trung Hieu +11 more
doaj +1 more source
Prediction of Prion Proteins in E. coli Based on Bimodal Sequence Characteristics
ABSTRACT Prions are infectious proteins that bear misfolded conformations capable of converting folded states into misfolded aggregates under physiologically relevant conditions. In mammals, prions cause deadly maladies including Creutzfeldt‐Jakob and chronic wasting disease. To date, several prion proteins have been identified in eukaryotes, primarily
Katherine Shreeve +5 more
wiley +1 more source
Gut mucin fucosylation dictates the entry of botulinum toxin complexes
Botulinum toxins (BoNTs) produced by Clostridium botulinum are the most potent known bacterial toxins. The BoNT complex from serotype B-Okra (LPTC/BOkra) exerts at least 80-fold higher oral toxicity in mice compared with that from serotype A1 (L-PTC/A62A)
Sho Amatsu +12 more
doaj +1 more source
ABSTRACT Radioresistance remains a key barrier in breast cancer (BC) treatment. Baicalein, a flavonoid from Scutellaria baicalensis, has shown potential to enhance radiosensitivity. This study investigates its efficacy and mechanism in radioresistant BC models. Radioresistant BC cell models were established via fractionated irradiation and validated by
Zitong Zhao +3 more
wiley +1 more source

